Analysis of time to death after transplantation when transplants are only given to patients in remission

被引:10
作者
Stram, DO [1 ]
Sather, H [1 ]
Wang, LT [1 ]
机构
[1] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA
关键词
Mantel-Byar test; proportional hazards model; time-dependent covariates;
D O I
10.2307/2533069
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The analysis in nonrandomized studies of the potential benefit to a patient which is derived from organ transplantation has been an important topic in survival analysis, having served as a key motivation for the development of such methods as the Mantel-Byar test and the Cox regression model with time-dependent covariates. This paper discusses an additional complication in the analysis of survival after transplantation that arises in cases when organ transplantation is only given to patients who are currently in remission from their illness after a first application of some other initial treatment. We show that the time-dependent covariates methods available in current survival analysis statistical programs are inadequate to properly handle the comparison of subsequent survival from transplant in this case, and propose a modification of the Mantel-Byar test specifically designed to deal with this difficulty The proposed method is contrasted with other approaches using data from studies of bone marrow transplantation in the treatment of childhood cancer.
引用
收藏
页码:1079 / 1086
页数:8
相关论文
共 16 条
[1]   A CRITICAL COMPARISON OF ALLOGENEIC BONE-MARROW TRANSPLANTATION AND CONVENTIONAL CHEMOTHERAPY AS TREATMENT FOR ACUTE NONLYMPHOCYTIC LEUKEMIA [J].
BEGG, CB ;
MCGLAVE, PB ;
BENNETT, JM ;
CASSILETH, PA ;
OKEN, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :369-378
[2]  
CARTER S, 1986, J CLIN ONCOL, V4, P260
[3]  
Carter S K, 1985, J Clin Oncol, V3, P1154
[4]   BONE-MARROW TRANSPLANTATION FOR HIGH-RISK CHILDHOOD LYMPHOBLASTIC-LEUKEMIA IN 1ST REMISSION - EXPERIENCE IN MRC UKALL-X [J].
CHESSELLS, JM ;
BAILEY, C ;
WHEELER, K ;
RICHARDS, SM .
LANCET, 1992, 340 (8819) :565-568
[5]   COVARIANCE ANALYSIS OF HEART-TRANSPLANT SURVIVAL DATA [J].
CROWLEY, J ;
HU, M .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1977, 72 (357) :27-36
[6]  
GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815
[7]  
GEHAN EA, 1990, CANCER-AM CANCER SOC, V65, P1429, DOI 10.1002/1097-0142(19900315)65:6<1429::AID-CNCR2820650630>3.0.CO
[8]  
2-B
[9]   COSTS AND BENEFITS OF ADJUVANT THERAPY IN BREAST-CANCER - A QUALITY-ADJUSTED SURVIVAL ANALYSIS [J].
GOLDHIRSCH, A ;
GELBER, RD ;
SIMES, RJ ;
GLASZIOU, P ;
COATES, AS .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :36-44
[10]  
GOODYEAR M, 1986, J CLIN ONCOL, V4, P259